findmyKOL

Sheldon Hirsch, MD

Basic profile

University of Iowa Hospitals and Clinics

ORCIDNone on fileNPI
RegionChicago, IL · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sheldon Hirsch is a Nephrology physician affiliated with University of Iowa Hospitals and Clinics. OpenAlex indexes 30 publications with 553 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
30publications

Distinct works indexed by OpenAlex.

553citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1717 S Wabash Ave
Chicago, IL 606161219

Telephone

312-913-0110

Provider last certified this registry record 16 Jul 2025.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    51%
    Aldosterone antagonist (MRA)13.3%
    Spironolactone100%
    Part D45 patients
    Loop diuretic6.8%
    Furosemide100%
    Part D26 patients

    + 8 more classes in this area

  • Other

    37%
    Drugs for treatment of hyperkalemia and hyperphosphatemia20.4%
    Velphoro45%Lokelma25%Auryxia23%Lanthanum Carbonate7%
    Part D<11 patients
    Phosphate Binder16.6%
    Sevelamer Carbonate100%
    Part D45 patients
  • Metabolism & gastrointestinal

    4.3%
    SGLT2 inhibitor2.5%
    Jardiance100%
    Part D<11 patients
    Corticosteroid1.9%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)32.6% facility · 67.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”